{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:13Z","timestamp":1792507513163,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.coms.2013.09.006","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T10:24:45Z","timestamp":1385375085000},"page":"75-81","source":"Crossref","is-referenced-by-count":17,"title":["Salivary Gland Disease in Sj\u00f6gren's Syndrome"],"prefix":"10.1016","volume":"26","author":[{"given":"Michael D.","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.coms.2013.09.006_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.rdc.2008.08.003","article-title":"Genes and Sjogren's syndrome","volume":"34","author":"Cobb","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.coms.2013.09.006_bib2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of Sjogren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.coms.2013.09.006_bib3","first-page":"8","article-title":"Primary Sjogren's syndrome: diagnostic criteria, clinical features, and disease activity","volume":"50","author":"Manthorpe","year":"1997","journal-title":"J\u00a0Rheumatol Suppl"},{"issue":"4","key":"10.1016\/j.coms.2013.09.006_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2011.10.002","article-title":"HLA and Sjogren's syndrome susceptibility. A meta-analysis of worldwide studies","volume":"11","author":"Cruz-Tapias","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.coms.2013.09.006_bib5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0198-8859(93)90130-S","article-title":"Molecular analysis of HLA class II genes in primary Sjogren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients","volume":"36","author":"Roitberg-Tambur","year":"1993","journal-title":"Hum Immunol"},{"key":"10.1016\/j.coms.2013.09.006_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1740-2557-5-1","article-title":"Immunogenetic mechanisms for the coexistence of organ-specific and systemic autoimmune diseases","volume":"5","author":"Fridkis-Hareli","year":"2008","journal-title":"J\u00a0Autoimmune Dis"},{"issue":"10","key":"10.1016\/j.coms.2013.09.006_bib7","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1002\/art.21347","article-title":"Antimuscarinic antibodies in Sjogren's syndrome: where are we, and where are we going?","volume":"52","author":"Dawson","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"17","key":"10.1016\/j.coms.2013.09.006_bib8","doi-asserted-by":"crossref","first-page":"9579","DOI":"10.1073\/pnas.97.17.9579","article-title":"Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype","volume":"97","author":"Matsui","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"10.1016\/j.coms.2013.09.006_bib9","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1113\/jphysiol.2004.064626","article-title":"M(3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice","volume":"558","author":"Nakamura","year":"2004","journal-title":"J\u00a0Physiol"},{"key":"10.1016\/j.coms.2013.09.006_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev.physiol.62.1.493","article-title":"Intracellular Ca2+ and Cl\u2013 channel activation in secretory cells","volume":"62","author":"Kidd","year":"2000","journal-title":"Annu Rev Physiol"},{"issue":"7","key":"10.1016\/j.coms.2013.09.006_bib11","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/eji.200738008","article-title":"Systemic increase in type I interferon activity in Sjogren's syndrome: a putative role for plasmacytoid dendritic cells","volume":"38","author":"Wildenberg","year":"2008","journal-title":"Eur J Immunol"},{"issue":"8","key":"10.1016\/j.coms.2013.09.006_bib12","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1073\/pnas.0510837103","article-title":"Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome","volume":"103","author":"Gottenberg","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.coms.2013.09.006_bib13","first-page":"1905","article-title":"Clinical course of primary Sjogren's syndrome: salivary, oral, and serologic aspects","volume":"27","author":"Gannot","year":"2000","journal-title":"J\u00a0Rheumatol Suppl"},{"issue":"3","key":"10.1016\/j.coms.2013.09.006_bib14","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/rheumatology\/39.3.234","article-title":"Sjogren's syndrome\u2013time for a new approach","volume":"39","author":"Dawson","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.coms.2013.09.006_bib15","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1038\/35010501","article-title":"Diffusional protein transport within the nucleus: a message in the medium","volume":"2","author":"Pederson","year":"2000","journal-title":"Nat Cell Biol"},{"issue":"10","key":"10.1016\/j.coms.2013.09.006_bib16","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/00220345840630100101","article-title":"Unstimulated and stimulated parotid salivary flow rate in individuals of different ages","volume":"63","author":"Heft","year":"1984","journal-title":"J\u00a0Dent Res"},{"issue":"5","key":"10.1016\/j.coms.2013.09.006_bib17","doi-asserted-by":"crossref","first-page":"M285","DOI":"10.1093\/gerona\/50A.5.M285","article-title":"Longitudinal analysis of parotid and submandibular salivary flow rates in healthy, different-aged adults","volume":"50","author":"Ship","year":"1995","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"issue":"7","key":"10.1016\/j.coms.2013.09.006_bib18","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/art.21945","article-title":"Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland","volume":"54","author":"Jonsson","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.coms.2013.09.006_bib19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/art.21764","article-title":"Antimuscarinic antibodies in primary Sjogren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells","volume":"54","author":"Dawson","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.coms.2013.09.006_bib20","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1002\/1529-0131(200007)43:7<1647::AID-ANR31>3.0.CO;2-P","article-title":"Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjogren's syndrome","volume":"43","author":"Waterman","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.coms.2013.09.006_bib21","first-page":"2406","article-title":"Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjogren's syndrome","volume":"30","author":"Walker","year":"2003","journal-title":"J\u00a0Rheumatol Suppl"},{"issue":"5","key":"10.1016\/j.coms.2013.09.006_bib22","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0002-9394(14)71084-0","article-title":"Adie syndrome as the initial sign of primary Sjogren syndrome","volume":"123","author":"Bachmeyer","year":"1997","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.coms.2013.09.006_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.59.1.48","article-title":"Impaired microvascular response to cholinergic stimuli in primary Sjogren's syndrome","volume":"59","author":"Kovacs","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.coms.2013.09.006_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/PL00011180","article-title":"Heart rate variability in patients with Sjogren's syndrome","volume":"19","author":"Tumiati","year":"2000","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.coms.2013.09.006_bib25","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1046\/j.1365-2249.1996.42748.x","article-title":"Circulating antibodies against rat parotid gland M3 muscarinic receptors in primary Sjogren's syndrome","volume":"104","author":"Bacman","year":"1996","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.coms.2013.09.006_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-0714.2001.300101.x","article-title":"Frequency and predictive value of the clinical manifestations in Sjogren's syndrome","volume":"30","author":"Al-Hashimi","year":"2001","journal-title":"J\u00a0Oral Pathol Med"},{"issue":"6","key":"10.1016\/j.coms.2013.09.006_bib27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.coms.2013.09.006_bib28","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.joms.2010.10.002","article-title":"Endoscopic treatment of salivary glands affected by autoimmune diseases","volume":"69","author":"Shacham","year":"2011","journal-title":"J\u00a0Oral Maxillofac Surg"},{"issue":"3","key":"10.1016\/j.coms.2013.09.006_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.coms.2009.05.001","article-title":"The bacteriology of salivary gland infections","volume":"21","author":"Brook","year":"2009","journal-title":"Oral Maxillofacial Surg Clin N Am"},{"issue":"4","key":"10.1016\/j.coms.2013.09.006_bib30","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/art.27318","article-title":"Increased expression of interleukin-7 in labial salivary glands of patients with primary Sj\u00f6gren's syndrome correlates with increased inflammation","volume":"62","author":"Bikker","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.coms.2013.09.006_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.md.0000157398.37679.47","article-title":"Circulating monoclonal immunoglobulins in Sjogren syndrome: prevalence and clinical significance in 237 patients","volume":"84","author":"Brito-Zeron","year":"2005","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.coms.2013.09.006_bib32","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sj\u00f6gren's syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sj\u00f6gren's syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.coms.2013.09.006_bib33","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","article-title":"Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects","volume":"88","author":"Baimpa","year":"2009","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.coms.2013.09.006_bib34","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1365-2362.2004.01417.x","article-title":"Myelodysplasia-associated autoimmunity: clinical and pathophysiologic concepts","volume":"34","author":"Voulgarelis","year":"2004","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 1","key":"10.1016\/j.coms.2013.09.006_bib35","first-page":"S65","article-title":"B\u00a0cell monoclonal proliferation in Sjogren's syndrome","volume":"3","author":"Voulgarelis","year":"2004","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.coms.2013.09.006_bib36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/ard.60.11.1007","article-title":"Lymphomas complicating Sjogren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells","volume":"60","author":"Mariette","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.coms.2013.09.006_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/1024533021000024058","article-title":"Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis","volume":"7","author":"Rossi","year":"2002","journal-title":"Hematology"},{"issue":"6","key":"10.1016\/j.coms.2013.09.006_bib38","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1053\/gast.1997.v112.pm9178679","article-title":"Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas","volume":"112","author":"Neumeister","year":"1997","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.coms.2013.09.006_bib39","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semarthrit.2013.04.004","article-title":"Malignant lymphoma in primary Sjogren's syndrome: an update on the pathogenesis and treatment","volume":"43","author":"Routsias","year":"2013","journal-title":"Semin Arthritis Rheum"},{"issue":"14","key":"10.1016\/j.coms.2013.09.006_bib40","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A\u00a0predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"1\u20132","key":"10.1016\/j.coms.2013.09.006_bib41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/10428199609045724","article-title":"Evaluation of the international index in the prognosis of high grade gastric malt lymphoma","volume":"24","author":"Castrillo","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.coms.2013.09.006_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-Hodgkin lymphoma in primary Sjogren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Medicine"}],"container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369913001155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369913001155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T15:23:00Z","timestamp":1539012180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042369913001155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1042369913001155"],"URL":"https:\/\/doi.org\/10.1016\/j.coms.2013.09.006","relation":{},"ISSN":["1042-3699"],"issn-type":[{"value":"1042-3699","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}